Rechallenge of oxaliplatin-containing regimens in the third- or later-line therapy for patients with heavily treated metastatic colorectal cancer

Lignende værker

• Bevacizumab plus chemotherapy as third- or later-line therapy in patients with heavily treated metastatic colorectal cancer
  af: Yang, Qiong, et al.
  Udgivet: (2015)
• P-154 Combined oxaliplatin, irinotecan and fluorouracil as a rescue regimen for heavily pretreated metastatic colorectal cancer patients
  af: Dos Santos Fernandes, G., et al.
  Udgivet: (2016)
• Capecitabine, Oxaliplatin, and Bevacizumab (BCapOx) Regimen for Metastatic Colorectal Cancer
  af: Garrett, Meghan J., et al.
  Udgivet: (2017)
• A phase II trial of S-1 monotherapy in metastatic colorectal cancer after failure of irinotecan- and oxaliplatin-containing regimens
  af: Jeung, H-C, et al.
  Udgivet: (2006)
• Glasgow PrognosticScore as a Predictor of BevacizumabEfficacy in the First-line Treatment with Metastatic Colorectal Cancer
  af: Huang, Yuanyuan, et al.
  Udgivet: (2019)